DEBRA GILHOOLY: Open Payments
NPI 1023222536 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 31 payments from 9 companies in 2025. Trend: 2023 $1,835 · 2024 $778 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $197 |
| Exeltis, USA Inc. | 6 | $125 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $107 |
| Biogen, Inc. | 3 | $83 |
| Astellas Pharma US Inc | 2 | $36 |
| Baxter Healthcare | 1 | $33 |
| Exact Sciences Corporation | 1 | $24 |
| MILLICENT US INC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $14 |
Products named: GEMTESA, SLYND, ZURZUVAE, MYFEMBREE, Veozah, PERCLOT, Cologuard Collection Kit, FEMLYV.
Industry payments across NY — which companies pay providers there.
